news Google’s AI co-scientist accelerates drug development 7 March 2025 | By Drug Target Review Google has introduced an AI-powered 'co-scientist' designed to accelerate biomedical research and drug discovery by generating scientific hypotheses and identifying novel therapeutic targets.
news Overcoming chemotherapy resistance in pancreatic cancer 10 July 2024 | By Drug Target Review Researchers have discovered that pancreatic cancer’s resistance to chemotherapy is related to the physical stiffness of the extracellular matrix.
news New AI model could help to overcome antibiotic resistance 27 March 2024 | By Drug Target Review Six molecules that had potent antibacterial effect against one of the world’s most dangerous antibiotic-resistant bacteria were generated.
news Breast cancer cells invade by a physical mechanism 15 November 2023 | By Drug Target Review Findings from using a 3D hydrogel to study how cancer cells physically tear the basement membrane offers promise for targeted treatment.
article Understanding intracellular processes improves LYTACs therapy 7 November 2023 | By Ellen Capon (Drug Target Review) New pathway involved in cellular protein degradation could develop LYTACs therapy and find new treatments for lysosome shortage disorders.
article Bioengineered instrument reveals hidden cancer cells 11 September 2023 | By Taylor Mixides (Drug Target Review) Scientists at Stanford University have engineered a biomolecule that can specifically remove mucins from cancer cells. This breakthrough could have a significant impact on future cancer therapies.
news New computational tool may fuel vaccine development 28 July 2023 | By Izzy Wood (Drug Target Review) La Jolla biologists harness machine learning and computational tools to make sense of immune system data.
news Weaponising SARS-CoV-2 spike protein against itself to prevent infection 21 February 2023 | By Izzy Wood (Drug Target Review) By creating a drug that is based on part of the SARS-CoV-2 spike protein, US and Finnish researchers can block the virus from entering cells.
news Scientists discover multiple pathways of the 5HT2a receptor activated by psychedelics 4 October 2022 | By Ria Kakkad (Drug Target Review) The new LSD-like compounds activated the 5HT2a receptor, a receptor stimulated by serotonin, without causing hallucinations.
news Researchers halt the growth of multiple myeloma in mice 27 July 2022 | By Ria Kakkad (Drug Target Review) Scientists from Stanford University have been able to halt the growth of multiple myeloma and diffuse large B cell lymphoma in mice with custom molecule sBCMA-Fc V3.
news New gene therapy improvement has massive potential 20 June 2022 | By Ria Kakkad (Drug Target Review) Scientists have developed a technology that can improve targeting specific organs and tissue types in gene therapy.
news Simple delivery method that enhances a promising cancer treatment 11 April 2022 | By Ria Kakkad (Drug Target Review) Scientists have developed a delivery method that enhances treatment by adding CAR T cells and specialising signalling proteins to a hydrogel that is injected next to a tumour.
news Molecular pathway shared by two neurodegenerative disorders found 3 March 2022 | By Ria Kakkad (Drug Target Review) Scientists have gained deeper knowledge about the mislocalisation of a protein, providing a possible therapeutic target that could have implications in treating dementia.
news New cryo-EM method reveals insight into blood disorders 15 February 2022 | By Ria Kakkad (Drug Target Review) A molecular cage, developed for use during cryo-EM, has provided researchers with new insights into a key cancer protein.
news 3D printed microneedle vaccine shows promise in animals 19 October 2021 | By Victoria Rees (Drug Target Review) Researchers have shown that a new microneedle vaccine patch was 10 times stronger at generating an immune response in animals than a subcutaneous injection.
